From Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs:

MersanaLogo
MersanaLogo—

Mersana is developing antibody drug conjugates to treat cancer.

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

© 2007-2020, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.